Max Lakomek Selected Research

erucylphosphohomocholine ErPC3

7/2010

Potential involvement of F0F1-ATP(synth)ase and reactive oxygen species in apoptosis induction by the antineoplastic agent erucylphosphohomocholine in glioblastoma cell lines : a mechanism for induction of apoptosis via the 18 kDa mitochondrial translocator protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Max Lakomek Research Topics

Disease

8	Glioma (Gliomas) 08/2012 - 09/2002
7	Glioblastoma (Glioblastoma Multiforme) 08/2012 - 07/2002
5	Brain Neoplasms (Brain Tumor) 08/2012 - 07/2002
5	Neoplasms (Cancer) 07/2012 - 10/2002
2	Diphtheria 02/2011 - 01/2003
2	Tetanus 02/2011 - 01/2003
1	Sarcoma (Soft Tissue Sarcoma) 02/2011
1	Ewing Sarcoma (Sarcoma, Ewing) 02/2011
1	Hypoglycemia (Reactive Hypoglycemia) 12/2010
1	Bradycardia 12/2010
1	Bronchial Spasm 12/2010
1	Muscle Spasticity (Spastic) 12/2010
1	Hemangioma (Angioma) 12/2010
1	Hyperkalemia 12/2010
1	Hypotension (Low Blood Pressure) 12/2010
1	Cardiotoxicity 05/2010
1	Infections 07/2009
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2009
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2009
1	Disease Progression 07/2009
1	Familial Cirrhosis with Pulmonary Hypertension 01/2003
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2003
1	Measles 01/2003
1	Mumps 01/2003
1	Poliomyelitis (Polio) 01/2003
1	Rubella (German Measles) 01/2003
1	Vaccine-Preventable Diseases 01/2003
1	Necrosis 09/2002
1	Astrocytoma (Pilocytic Astrocytoma) 07/2002
1	Acute Kidney Injury (Acute Renal Failure) 05/2002

Drug/Important Bio-Agent (IBA)

5	Antineoplastic Agents (Antineoplastics)IBA 02/2011 - 07/2002
4	Proteins (Proteins, Gene)FDA Link 08/2012 - 01/2008
4	erucylphosphocholineIBA 12/2004 - 07/2002
2	LigandsIBA 01/2008 - 07/2005
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 08/2012
1	Glutamic Acid (Glutamate)FDA Link 08/2012
1	RNA (Ribonucleic Acid)IBA 08/2012
1	EnzymesIBA 08/2012
1	Antisense RNA (Anti-Sense RNA)IBA 08/2012
1	Glutamate Receptors (Glutamate Receptor)IBA 08/2012
1	AcidsIBA 08/2012
1	Small Interfering RNA (siRNA)IBA 07/2012
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 12/2010
1	Albuterol (Salbutamol)FDA LinkGeneric 12/2010
1	Blood Glucose (Blood Sugar)IBA 12/2010
1	Propranolol (Inderal)FDA LinkGeneric 12/2010
1	PotassiumIBA 12/2010
1	ElectrolytesIBA 12/2010
1	erucylphosphohomocholine ErPC3IBA 07/2010
1	erucylphospho- N,N,N- trimethylpropylammoniumIBA 07/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2010
1	AnthracyclinesIBA 05/2010
1	Voltage-Dependent Anion ChannelsIBA 01/2008
1	Adenine NucleotidesIBA 01/2008
1	5,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA 01/2008
1	PK 11195 (PK11195)IBA 01/2008
1	Coloring Agents (Dyes)IBA 01/2008
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2008
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2008
1	Mitochondrial Permeability Transition PoreIBA 01/2008
1	GABA-A Receptors (GABA(A) Receptor)IBA 07/2005
1	isoquinolineIBA 07/2005
1	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 07/2005
1	Carrier Proteins (Binding Protein)IBA 07/2005
1	Phosphotransferases (Kinase)IBA 12/2004
1	RhodaminesIBA 12/2003
1	Fluorescein (Funduscein)FDA LinkGeneric 12/2003
1	1-O-pentylglycerolIBA 12/2003
1	Drinking WaterIBA 01/2003
1	CopperIBA 01/2003
1	AntibodiesIBA 01/2003
1	Cytostatic AgentsIBA 01/2003
1	BradykininIBA 10/2002
1	Pharmaceutical PreparationsIBA 10/2002
1	CaspasesIBA 09/2002
1	Death Domain ReceptorsIBA 09/2002
1	TNF-Related Apoptosis-Inducing LigandIBA 09/2002
1	miltefosine (Impavido)IBA 07/2002
1	Cisplatin (Platino)FDA LinkGeneric 05/2002
1	sodium thiosulfate FDA Link 05/2002

Therapy/Procedure

4	Therapeutics 02/2011 - 07/2009
4	Drug Therapy (Chemotherapy) 07/2009 - 07/2002
1	Combination Drug Therapy (Combination Chemotherapy) 02/2011
1	Stem Cell Transplantation 07/2009
1	Transplantation 07/2009